In the Anited States Court of Federal Claims
OFFICE OF SPECIAL MASTERS No. 19-1709V
(not to be published) Hk ok Ok ok ok ok ok ok ok ok ok ok oe ok ok ok ok ok ok ok ok ok ok ok * ANGELA LEE, : * Filed: April 22, 2021 Petitioner, * * * V. * Decision by Stipulation; Damages; * Influenza (“Flu”) Vaccine; Guillain-Barré SECRETARY OF HEALTH AND : syndrome (“GBS”). HUMAN SERVICES, . * Respondent. * * *
2h 2K Ok ok ok ok ok ok Ok OK ok ok ok ok ok ok KOO Ok ok Ok KOK OOK
David Carney, Green & Schafle LLC, Philadelphia, PA, for Petitioner Emilie Williams, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION!
On November 9, 2019, Angela Lee (“Petitioner”) filed a petition, seeking compensation under the National Vaccine Injury Compensation Program (“the Vaccine Program”).” Pet., ECF No. 1. Petitioner alleges she developed Guillain-Barré syndrome (“GBS”) within the time period set forth in the Table, or in the alternative, that her alleged GBS was caused by the flu vaccination she received on October 3, 2017; she further alleges that she experienced residual effects of this condition for more than six months. See Stipulation { 2, 4, dated April 22, 2021 (ECF No. 33); see also Petition.
' Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Jd.
* The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10-34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa. Respondent denies “that petitioner sustained a Table injury, and denies that the flu vaccine is the cause of petitioner’s alleged GBS, chronic inflammatory demyelinating polyneuropathy (“CIDP”), or any other injury or her current condition.” See Stipulation { 6. Nonetheless, both parties, while maintaining their above-stated positions, agreed in a stipulation filed April 22, 2021 that the issues before them can be settled and that a decision should be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.
The stipulation awards: a lump sum of $60,000.00 in the form of a check payable to petitioner.
Stipulation { 8. This award represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court is directed to enter judgment herewith.?
IT IS SO ORDERED.
s/ Katherine E. Oler Katherine E. Oler Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice renouncing their right to seek review. IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS
ANGELA LEE, ) ) Petitioner, ) ) Vv. ) No. 19-1709V
) Special Master Oler SECRETARY OF ) HEALTH AND HUMAN SERVICES, ) ) Respondent. ) )
STIPULATION
The parties hereby stipulate to the following matters:
1. Petitioner Angela Lee (“petitioner”) filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the “Vaccine Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt of the influenza (“flu”) vaccine, which vaccine is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3 (a).
2. Petitioner received a flu vaccine on or about October 3, 2017.
3. The vaccine was administered within the United States.
4. Petitioner alleges that she developed Guillain-Barre Syndrome (“GBS”) within the time period set forth in the Table, or in the alternative, that her alleged GBS was caused by the vaccine. She further alleges that she experienced residual effects of this condition for more than six months,
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages as a result of her condition. 6. Respondent denies that petitioner sustained a Table injury, and denies that the flu vaccine is the cause of petitioner’s alleged GBS, chronic inflammatory demyelinating polyneuropathy (“CIDP”), or any other injury or her current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation described in paragraph 9 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with the terms of this Stipulation, and after petitioner has filed an election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue the following vaccine compensation payment:
A lump sum of $60,000.00 in the form of a check payable to petitioner. This amount
represents compensation for all damages that would be available under 42 U.S.C.
§ 300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after petitioner has filed both a proper and timely election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings before the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this petition.
10. Petitioner and her attorney represent that they have identified to respondent all known sources of payment for items or services for which the Program is not primarily liable under 42 U.S.C. § 300a
Free access — add to your briefcase to read the full text and ask questions with AI
In the Anited States Court of Federal Claims
OFFICE OF SPECIAL MASTERS No. 19-1709V
(not to be published) Hk ok Ok ok ok ok ok ok ok ok ok ok oe ok ok ok ok ok ok ok ok ok ok ok * ANGELA LEE, : * Filed: April 22, 2021 Petitioner, * * * V. * Decision by Stipulation; Damages; * Influenza (“Flu”) Vaccine; Guillain-Barré SECRETARY OF HEALTH AND : syndrome (“GBS”). HUMAN SERVICES, . * Respondent. * * *
2h 2K Ok ok ok ok ok ok Ok OK ok ok ok ok ok ok KOO Ok ok Ok KOK OOK
David Carney, Green & Schafle LLC, Philadelphia, PA, for Petitioner Emilie Williams, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION!
On November 9, 2019, Angela Lee (“Petitioner”) filed a petition, seeking compensation under the National Vaccine Injury Compensation Program (“the Vaccine Program”).” Pet., ECF No. 1. Petitioner alleges she developed Guillain-Barré syndrome (“GBS”) within the time period set forth in the Table, or in the alternative, that her alleged GBS was caused by the flu vaccination she received on October 3, 2017; she further alleges that she experienced residual effects of this condition for more than six months. See Stipulation { 2, 4, dated April 22, 2021 (ECF No. 33); see also Petition.
' Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Jd.
* The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10-34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa. Respondent denies “that petitioner sustained a Table injury, and denies that the flu vaccine is the cause of petitioner’s alleged GBS, chronic inflammatory demyelinating polyneuropathy (“CIDP”), or any other injury or her current condition.” See Stipulation { 6. Nonetheless, both parties, while maintaining their above-stated positions, agreed in a stipulation filed April 22, 2021 that the issues before them can be settled and that a decision should be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.
The stipulation awards: a lump sum of $60,000.00 in the form of a check payable to petitioner.
Stipulation { 8. This award represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court is directed to enter judgment herewith.?
IT IS SO ORDERED.
s/ Katherine E. Oler Katherine E. Oler Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice renouncing their right to seek review. IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS
ANGELA LEE, ) ) Petitioner, ) ) Vv. ) No. 19-1709V
) Special Master Oler SECRETARY OF ) HEALTH AND HUMAN SERVICES, ) ) Respondent. ) )
STIPULATION
The parties hereby stipulate to the following matters:
1. Petitioner Angela Lee (“petitioner”) filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the “Vaccine Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt of the influenza (“flu”) vaccine, which vaccine is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3 (a).
2. Petitioner received a flu vaccine on or about October 3, 2017.
3. The vaccine was administered within the United States.
4. Petitioner alleges that she developed Guillain-Barre Syndrome (“GBS”) within the time period set forth in the Table, or in the alternative, that her alleged GBS was caused by the vaccine. She further alleges that she experienced residual effects of this condition for more than six months,
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages as a result of her condition. 6. Respondent denies that petitioner sustained a Table injury, and denies that the flu vaccine is the cause of petitioner’s alleged GBS, chronic inflammatory demyelinating polyneuropathy (“CIDP”), or any other injury or her current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation described in paragraph 9 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with the terms of this Stipulation, and after petitioner has filed an election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue the following vaccine compensation payment:
A lump sum of $60,000.00 in the form of a check payable to petitioner. This amount
represents compensation for all damages that would be available under 42 U.S.C.
§ 300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after petitioner has filed both a proper and timely election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings before the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this petition.
10. Petitioner and her attorney represent that they have identified to respondent all known sources of payment for items or services for which the Program is not primarily liable under 42 U.S.C. § 300aa-15(g), including State compensation programs, insurance policies, Federal or State health benefits programs (other than Title XIX of the Social Security Act (42
U.S.C. § 1396 et seq.)), or entities that provide health services on a pre-paid basis. 11. Payment made pursuant to paragraph 9 and any amounts awarded pursuant to paragraph 10 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i), subject to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award for attorneys’ fees and litigation costs and past unreimbursable expenses, the money provided pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C. § 300aa-15(g) and (h).
13. In return for the payments described in paragraphs 9 and 10, petitioner, in her individual capacity, and on behalf of her heirs, executors, administrators, successors or assigns, does forever irrevocably and unconditionally release, acquit and discharge the United States and the Secretary of Health and Human Services from any and all actions or causes of action (including agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever kind or nature) that have been brought, could have been brought, or could be timely brought in the Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 et seq., on account of, or in any way growing out of, any and all known or unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or alleged to have resulted from, the flu vaccination administered on October 3, 2017, as alleged by petitioner in a petition for vaccine compensation filed on or about November 4, 2019, in the United States Court of Federal Claims as petition No. 19-1709V.
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties. 15. Ifthe special master fails to issue a decision in complete conformity with the terms of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a decision that is in complete conformity with the terms of this Stipulation, then the parties’ settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except as otherwise noted in paragraph 10 above. There is absolutely no agreement on the part of the parties hereto to make any payment or to do any act or thing other than is herein expressly stated and clearly agreed to. The parties further agree and understand that the award described in this Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or amount of damages, and further, that a change in the nature of the injury or condition or in the items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the Secretary of Health and Human Services that the immunization caused petitioner’s alleged GBS, CIDP, or any other injury or her current condition.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’ s heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
~~~ ~~ ~~ ™~ ™~ O™CO™OF™: Respectfully submitted,
PETITIONER:
(ng Sev.
ANGE#/A LEE
ATTORNEY OF RECORD FOR PETITIONER:
DAVID J. CARNEY, ES Green & Schafle, LLC 2332 South Broad Street Philadelphia, PA 19145 (215) 326-9256
AUTHORIZED REPRESENTATIVE OF THE SECRETARY OF HEALTH AND HUMAN SERVICES:
CAPT Dake Wuthlar., PN Se, fer
TAMARA OVERBY
Acting Director, Division of Injury Compensation Programs
Healthcare Systems Bureau
Health Resources and Services Administration
U.S. Department of Health and Human Services
5600 Fishers Lane, 08N146B
Rockville, MD 20857
Dated: of 2.82.1
AUTHORIZED REPRESENTATIVE OF THE ATTORNEY GENERAL:
HEATHER L. PEARLMAN Acting Deputy Director Torts Branch
Civil Division
U.S. Department of Justice P.O. Box 146
Benjamin Franklin Station Washington, DC 20044-0146
ATTORNEY OF RECORD FOR RESPONDENT:
Emits wthanr
EMILIE F. WILLIAMS Trial Attorney
Torts Branch
Benjamin Franklin Station Washington, DC 20044-0146 (202) 305-0124
(202) 305-0124 emilie.williams@usdoj.gov